1. Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors. Issue 12 (5th January 2009) Authors: Westhovens, R; Robles, M; Ximenes, A C; Nayiager, S; Wollenhaupt, J; Durez, P; Gomez-Reino, J; Grassi, W; Haraoui, B; Shergy, W; Park, S-H; Genant, H; Peterfy, C; Becker, J-C; Covucci, A; Helfrick, R; Bathon, J Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 12(2009) Page Start: 1870 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Low prevalence of Pneumocystis pneumonia in hospitalized patients with systemic lupus erythematosus: review of a clinical data warehouse. (December 2017) Authors: Kapoor, T M; Mahadeshwar, P; Nguyen, S; Li, J; Kapoor, S; Bathon, J; Giles, J; Askanase, A Journal: Lupus Issue: Volume 26:Number 14(2017) Page Start: 1473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0121 Enbrel® (etanercept) vs. methotrexate (mtx) in early rheumatoid arthritis (era trial): two-year follow-up. (1st June 2001) Authors: Genovese, M; Martin, RW; Fleischmann, R; Keystone, E; Bathon, J; Spencer-Green, G; Finck, B Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Issue 10 (12th September 2008) Authors: Aletaha, D; Landewe, R; Karonitsch, T; Bathon, J; Boers, M; Bombardier, C; Bombardieri, S; Choi, H; Combe, B; Dougados, M; Emery, P; Gomez-Reino, J; Keystone, E; Koch, G; Kvien, T K; Martin-Mola, E; Matucci-Cerinic, M; Michaud, K; O'Dell, J; Paulus, H Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 10(2008) Page Start: 1360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes. Issue 11 (6th August 2011) Authors: Bathon, J; Robles, M; Ximenes, A C; Nayiager, S; Wollenhaupt, J; Durez, P; Gomez-Reino, J; Grassi, W; Haraoui, B; Shergy, W; Park, S-H; Genant, H; Peterfy, C; Becker, J-C; Covucci, A; Moniz Reed, D; Helfrick, R; Westhovens, R Journal: Annals of the rheumatic diseases Issue: Volume 70:Issue 11(2011) Page Start: 1949 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0192 Combination therapy of leflunomide (lef) and methotrexate (mtx) is effective and well tolerated in rheumatoid arthritis (ra) patients inadequately responding to methotrexate (mtx) alone. (1st June 2001) Authors: Kremer, JM; Genovese, M; Cannon, GW; Caldwell, JR; Cush, JJ; Luggen, ME; Furst, DE; Crawford, B; Bathon, J Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗